Jenscare Scientific (HKG:9877) said its Ken-Valve Transcatheter Aortic Valve Replacement System received approval from Hong Kong's Department of Health, according to a Monday bourse filing.
Ken-Valve is used to treat aortic regurgitation and combined aortic stenosis, the filing said.